Qube Research & Technologies (QRT)
XGN icon

Qube Research & Technologies (QRT)’s Exagen XGN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-174,240
Closed -$1.06M – 4207
2025
Q4 		$1.06M Buy
174,240
+97,588
+127% +$888K ﹤0.01% 2534
2025
Q3 		$842K Buy
+76,652
New +$679K ﹤0.01% 2583
2024
Q3 		– Sell
-204
Closed -$372 – 4216
2024
Q2 		$372 Hold
204
– – ﹤0.01% 3335
2024
Q1 		$324 Hold
204
– – ﹤0.01% 4115
2023
Q4 		$406 Hold
204
– – ﹤0.01% 3931
2023
Q3 		$500 Buy
+204
New +$517 ﹤0.01% 3681

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Qube Research & Technologies (QRT)'s XGN Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Exagen (XGN) in Q1 2026, closing a stake of 174,240 shares — an estimated $1.06M sold.

Qube Research & Technologies (QRT) first reported a position in XGN in Q3 2023 and held it in 6 quarters. The position peaked at $1.06M in Q4 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Exagen position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 174,240 Exagen shares in Q1 2026, an estimated $1.06M.
  • Qube Research & Technologies (QRT) first reported a position in Exagen in Q3 2023 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Exagen position peaked at $1.06M in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.